Skip to main content

Center for Biologics Evaluation and Research (CBER) Publications.

Annual reports and publications created by the Center for Biologics Evaluation and Research (CBER) have been digitized and made freely available on the Web as a service of the NIH Library.

PART OF
National Institutes of Health Library
FEDLINK - United States Federal Collection
More right-solid
SHOW DETAILS
up-solid down-solid
eye
Title
Date Published
Creator
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.) Division of Transfusion Science
texts
eye 1,405
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.) Division of Biochemistry and Biophysics
texts
eye 634
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.) Division of Hematology
texts
eye 573
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.) Division of Product Quality Control
texts
eye 493
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.) Division of Virology
texts
eye 424
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.) Division of Bacterial Products
texts
eye 401
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy
Center for Biologics Evaluation and Research (CBER) Publications.
by Center for Biologics Evaluation and Research (U.S.)
texts
eye 279
favorite 0
comment 0
Topics: Biological products, Drugs, Pharmaceutical policy